TTFCA (Total Triterpenic Fraction).

Prolyl and lysyl hydroxylase need ascorbate to stabilise the collagen triple helix, so vitamin C is the rate-setting cofactor for the collagen synthesis centella asiatica stimulates. Without it the extra signalling has nothing to build on.

Collagen peptides supply glycine, proline and hydroxyproline building blocks while centella's asiaticoside signals fibroblasts to lay down matrix. Substrate and signal work on the same output.

Proline and its hydroxylated form make up a large share of collagen's amino acid backbone. Supplying it feeds the synthesis step centella upregulates.

Lysyl oxidase is a copper-dependent enzyme that crosslinks new collagen and elastin fibres into mature, resilient tissue. Newly stimulated collagen stays weak without adequate copper.

Zinc is a cofactor for the metalloproteinases and DNA polymerases that remodel connective tissue during repair. It supports the same tissue turnover centella acts on.

Hyaluronic acid holds water in the ground substance while centella-driven collagen supplies the fibrous scaffold. Skin and connective tissue need both fractions of the matrix.

Pine bark procyanidins bind to collagen and elastin and support capillary wall integrity, the same venous tone target as centella's titrated triterpenes. They are combined in leg and vein formulas.

Grape seed oligomeric procyanidins bind connective tissue proteins and reduce capillary permeability alongside centella's action on vein wall collagen. The mechanisms sit on the same structure.

Ruscogenins raise venous tone through adrenergic receptor activity while centella strengthens the vein wall matrix itself. European venotonic formulas pair the two routinely.

Bioavailable silicon participates in glycosaminoglycan and collagen crosslink formation, giving structure to the matrix centella stimulates. Both feed connective tissue architecture.

Asiaticoside and madecassoside are large glycosylated triterpenes with poor membrane permeability, which is the usual reason a phytosome-type phospholipid complex is used. Complexing the fraction with phosphatidylcholine gives it a lipid-compatible shell to cross with. This is formulation chemistry described for the compound class, not an absorption figure measured for this fraction here.

Alpha-tocopherol works in the lipid membrane while the triterpene fraction acts on fibroblast signalling in the extracellular matrix, so the two occupy different compartments of the same tissue. Vitamin E also protects the oil phase a triterpene extract is often carried in. The pairing is formulation and compartment logic rather than a combination trial.

MSM supplies bioavailable sulphur used in the disulphide cross-links of structural proteins, while the triterpenic fraction acts on the fibroblast side of collagen synthesis. They meet at connective tissue from different directions. No study in the available set measured them together.

Orthosilicic acid is involved in the cross-linking of glycosaminoglycans with the collagen network, a structural step downstream of the collagen production the triterpene fraction influences. Skin and connective-tissue formulas combine them for that sequence. The relationship is mechanistic; no combination result is being claimed.

Manganese is the metal cofactor for the glycosyltransferases that build the glycosaminoglycan chains of proteoglycans in connective tissue. Fibroblast activity encouraged by a triterpene fraction still depends on those enzymes having their cofactor. This is settled cofactor biochemistry, not a claim about the combination in people.

Collagen cross-linking runs through hydroxylation of lysine residues and their oxidative coupling by lysyl oxidase, so lysine supply sits upstream of a stable collagen fibre. A triterpene fraction that acts on fibroblast collagen output does not substitute for that substrate. The relationship is textbook matrix biochemistry.

Bacosides and the Centella triterpenes are both saponin-class plant glycosides used in the same traditional nootropic context, and both have preclinical work on neuronal signalling. Formulators combine them on that shared history. Nothing in the available literature measured the pair, so this is the weakest kind of link.

Ginkgo flavone glycosides and terpene lactones act on platelet and vascular tone signalling, while Centella triterpenes have been described for effects on the vessel wall and connective tissue. Products aimed at circulation comfort carry both. The overlap is positional and mechanistic, without a combination study here.

Astaxanthin distributes into membranes and quenches singlet oxygen, a different job from the fibroblast-signalling role attributed to the triterpene fraction. Skin formulas pair a matrix-active with a membrane antioxidant for that reason. Read it as complementary chemistry, not a measured joint effect.

Resveratrol and the Centella triterpenes both show up in preclinical work on nuclear factor signalling and oxidative stress markers in connective tissue and neurons. The overlap is at the level of cell-culture and animal signalling. No human combination data exists in the set available.

Asiatic acid and madecassic acid, the aglycone half of the fraction, are lipophilic and disperse better in a fat phase than in water. A medium-chain triglyceride carrier keeps them in solution in a softgel or a liquid. This is dissolution chemistry, and it does not describe a clinical result.

The triterpene glycosides in the fraction are converted to their absorbable aglycones mainly by gut bacterial glycosidases rather than by pancreatic enzymes, so a standard digestive enzyme blend is not the step that does that work. Anyone assuming pancreatic enzymes drive this conversion has the pathway wrong. The row is here to record the distinction, not to recommend a pairing.